IRIS Accounts Production v25.4.0.155 07140073 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh071400732024-03-31071400732025-03-31071400732024-04-012025-03-31071400732023-03-31071400732023-04-012024-03-31071400732024-03-3107140073ns15:EnglandWales2024-04-012025-03-3107140073ns14:PoundSterling2024-04-012025-03-3107140073ns10:Director12024-04-012025-03-3107140073ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3107140073ns10:SmallEntities2024-04-012025-03-3107140073ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3107140073ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3107140073ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3107140073ns10:FullAccounts2024-04-012025-03-3107140073ns10:Director22024-04-012025-03-3107140073ns10:Director32024-04-012025-03-3107140073ns10:RegisteredOffice2024-04-012025-03-3107140073ns5:CurrentFinancialInstruments2025-03-3107140073ns5:CurrentFinancialInstruments2024-03-3107140073ns5:Non-currentFinancialInstruments2025-03-3107140073ns5:Non-currentFinancialInstruments2024-03-3107140073ns5:ShareCapital2025-03-3107140073ns5:ShareCapital2024-03-3107140073ns5:SharePremium2025-03-3107140073ns5:SharePremium2024-03-3107140073ns5:CapitalRedemptionReserve2025-03-3107140073ns5:CapitalRedemptionReserve2024-03-3107140073ns5:RetainedEarningsAccumulatedLosses2025-03-3107140073ns5:RetainedEarningsAccumulatedLosses2024-03-3107140073ns5:FurnitureFittings2024-04-012025-03-3107140073ns5:ComputerEquipment2024-04-012025-03-3107140073ns5:FurnitureFittings2024-03-3107140073ns5:ComputerEquipment2024-03-3107140073ns5:FurnitureFittings2025-03-3107140073ns5:ComputerEquipment2025-03-3107140073ns5:FurnitureFittings2024-03-3107140073ns5:ComputerEquipment2024-03-3107140073ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3107140073ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3107140073ns5:MoreThanFiveYearsns5:Non-currentFinancialInstruments2025-03-3107140073ns5:MoreThanFiveYearsns5:Non-currentFinancialInstruments2024-03-3107140073ns10:Director112024-03-3107140073ns10:Director112023-03-3107140073ns10:Director112024-04-012025-03-3107140073ns10:Director112023-04-012024-03-3107140073ns10:Director112025-03-3107140073ns10:Director112024-03-31
REGISTERED NUMBER: 07140073 (England and Wales)












INFORM HEALTH LIMITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025






INFORM HEALTH LIMITED (REGISTERED NUMBER: 07140073)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


INFORM HEALTH LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: Ms S Bunn
Mr A Denman
Mr J Bassington





REGISTERED OFFICE: Aura Business Centre
Heath Road
Skegness
Lincolnshire
PE25 3SJ





REGISTERED NUMBER: 07140073 (England and Wales)





ACCOUNTANTS: Dexter & Sharpe (Skegness)
Chartered Certified Accountants
26 Ida Road
Skegness
Lincolnshire
PE25 2AR

INFORM HEALTH LIMITED (REGISTERED NUMBER: 07140073)

BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 3 52,653 37,632

CURRENT ASSETS
Stocks 42,971 -
Debtors 4 1,371,636 1,516,810
Cash at bank 937,340 441,174
2,351,947 1,957,984
CREDITORS
Amounts falling due within one year 5 1,821,101 1,518,939
NET CURRENT ASSETS 530,846 439,045
TOTAL ASSETS LESS CURRENT
LIABILITIES

583,499

476,677

CREDITORS
Amounts falling due after more than one
year

6

-

(37,984

)

PROVISIONS FOR LIABILITIES (13,163 ) (9,408 )
NET ASSETS 570,336 429,285

CAPITAL AND RESERVES
Called up share capital 2,247 2,247
Share premium 65,247 65,247
Capital redemption reserve 753 753
Retained earnings 502,089 361,038
SHAREHOLDERS' FUNDS 570,336 429,285

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

INFORM HEALTH LIMITED (REGISTERED NUMBER: 07140073)

BALANCE SHEET - continued
31 MARCH 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 December 2025 and were signed on its behalf by:





Ms S Bunn - Director


INFORM HEALTH LIMITED (REGISTERED NUMBER: 07140073)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents the sale of software licences, implementation fees and support contracts net of VAT.

Licence income is recognised when contracts are agreed and is not generally refundable to customers. Implementation income is recognised when the service aspects of the software sale are delivered.
Income on support contracts is recognised as the right to consideration arises over the term of the contract.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on reducing balance
Computer equipment - Straight line over 4 years

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 34 (2024 - 29 ) .

INFORM HEALTH LIMITED (REGISTERED NUMBER: 07140073)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


3. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 April 2024 34,665 85,160 119,825
Additions 17,609 15,762 33,371
Disposals - (6,285 ) (6,285 )
At 31 March 2025 52,274 94,637 146,911
DEPRECIATION
At 1 April 2024 19,166 63,027 82,193
Charge for year 4,986 13,364 18,350
Eliminated on disposal - (6,285 ) (6,285 )
At 31 March 2025 24,152 70,106 94,258
NET BOOK VALUE
At 31 March 2025 28,122 24,531 52,653
At 31 March 2024 15,499 22,133 37,632

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 1,273,698 1,436,137
Other debtors 97,938 80,673
1,371,636 1,516,810

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 37,984 60,714
Trade creditors 291,521 340,852
Corporation Tax 109,915 100,291
Social security and pensions 42,998 31,350
VAT 178,590 246,577
Other creditors 1,883 196
Directors' current accounts 3,679 3,679
Deferred income 1,098,674 731,605
Accrued expenses 55,857 3,675
1,821,101 1,518,939

6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
CBILs loan - 37,984

INFORM HEALTH LIMITED (REGISTERED NUMBER: 07140073)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

2025 2024
£    £   
Ms S Bunn
Balance outstanding at start of year - (45 )
Amounts repaid - 45
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - -